glp 1 agonist cardiovascular outcomes outcome studies with GLP-1 receptor GLP-1 receptor agonists and cardiovascular
Description
To support our research and testing, we may earn a commission if you sign up or purchase through certain links on this page at no additional cost to you
The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).
This blog covers the impact of high-fiber foods, protein-rich meals, probiotics, allulose, and intermittent fasting on GLP-1
- **Slow digestion:** Delaying stomach emptying to prevent spikes in sugar levels after meals
GLP-1 drugs have become a game-changer in treating obesity and type 2 diabetes, forecast to reach a $100 billion market value by 2030
